The market is being driven by the increasing adoption of mineral supplements for managing chronic conditions due to a significant portion of the population grappling with diseases like cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical firms are conducting social campaigns to encourage healthier lifestyles and supplement usage. For example, in February 2023, Torrent Pharmaceuticals Ltd unveiled a TV campaign named #BeShelcalStrong, aimed at boosting awareness about calcium deficiency and its impacts on daily life.
RNA Analysis Market size was valued at USD 5.1 billion in 2023 and is poised to grow from USD 5.79 billion in 2024 to USD 15.94 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).
The upsurge in sedentary lifestyles and consumption of unhealthy diets has resulted in a higher number of people experiencing nutritional deficiencies. Proper body functioning requires varying mineral proportions. Insufficient minerals can lead to problems like fatigue, weak bones, and a compromised immune system. According to NutraIngredients-USA data, iron deficiency is most prevalent in the U.S. population. Additionally, government initiatives promoting healthier lifestyles are further stimulating market growth.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/rna-analysis-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The RNA Analysis Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global RNA Analysis Market is segmented by Product, Technology, Application, End User and region.
Based on Product, the market is segmented into Reagents/Consumables, Instruments, Software and Services.
Based on Technology, the market is segmented into Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference.
Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Toxicogenomics and Comparative Transcriptomics.
Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Institutes and Contract Research Organizations.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
RNA Analysis Market – Regional Analysis:
In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development.
On the other hand, the Asia Pacific (APAC) region is poised to chart the swiftest CAGR during the forecast period, projected at 11.23%. This projection is underpinned by the escalating governmental and corporate investments catalyzing biotechnology research across APAC nations. Japan, in particular, boasts substantial governmental and non-governmental support for advancing biotech research, providing substantial funding in the medical and life sciences sectors.
Furthermore, the APAC region’s appeal is magnified by its reputation for cost-effective manufacturing services, attracting manufacturers to set their sights on this promising landscape. Strategic initiatives like partnerships also factor into the growth trajectory. Notably, in January 2020, Genetron Holdings Ltd. forged a strategic partnership with Thermo Fisher Scientific, a move aimed at extending precision cancer monitoring and diagnosis within China’s public hospitals.
Top Market Players in RNA Analysis Market are:
AxioMed LLC (U.S.)
Stryker (U.S.)
Orthofix (U.S.)
Globus Medical (U.S.)
Johnson & Johnson Services, Inc (U.S.)
B. Braun Melsungen AG (Germany)
Zimmer Biomet (U.S.)
Medtronic (Ireland)
Joimax GmbH (Germany)
VTI – Vertebral Technologies, Inc (U.S.)
RTI Surgical (U.S.)
Synergy Spine Solutions Inc. (Canada)
RNA Analysis Market Recent Developments;
In 2023, Thermo Fisher Scientific announced the launch of its new RNA analysis platform, the Ion GeneStudio S5 Prime.
In 2023, Agilent Technologies introduced a new line of RNA analysis reagents for use with its Bioanalyzer 2100 platform.
In 2023, Illumina announced the launch of its new RNA analysis software, the BaseSpace RNA Analysis Suite.
You may Also Like
https://medium.com/@kathan.trivedi/th%E1%BB%8B-tr%C6%B0%E1%BB%9Dng-b%C3%AA-t%C3%B4ng-t%E1%BB%95ng-quan-ng%C3%A0nh-v%C3%A0-xu-h%C6%B0%E1%BB%9Bng-m%E1%BB%9Bi-n%E1%BB%95i-2f1eba3ca149
https://medium.com/@kathan.trivedi/th%E1%BB%8B-tr%C6%B0%E1%BB%9Dng-than-xu-h%C6%B0%E1%BB%9Bng-c%C6%A1-h%E1%BB%99i-t%C4%83ng-tr%C6%B0%E1%BB%9Fng-v%C3%A0-tri%E1%BB%83n-v%E1%BB%8Dng-t%C6%B0%C6%A1ng-lai-5471e5874e9c
Forward-Looking Insights
The RNA Analysis Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
